Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Boffa

Showing results (101-110 of 209) with videos related to

Pageof 21
Sort By:
The Annals of Thoracic Surgery|December 16, 2014
Hospital readmission after pulmonary lobectomy is not affected by surgical approachRoland Assi, Daniel J Wong, Daniel J Boffa, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 20, 2015
Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBaseJia Liu, Jacquelyn G Hancock, Amy C Moreno, et al.
The Annals of Thoracic Surgery|December 22, 2014
Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgeryJacquelyn G Hancock, Joshua E Rosen, Alberto Antonicelli, et al.
JAMA Oncology|November 11, 2021
Understanding the Implications of Medicaid Expansion for Cancer Care in the US: A ReviewTheresa Ermer, Samantha L Walters, Maureen E Canavan, et al.
JAMA Network Open|September 29, 2020
Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care ActMichelle C Salazar, Maureen E Canavan, Samantha L Walters, et al.
The Annals of Thoracic Surgery|November 7, 2020
A National Study of Surgically Managed Atypical Pulmonary Carcinoid TumorsSamantha L Walters, Maureen E Canavan, Michelle C Salazar, et al.
Clinical Lung Cancer|October 27, 2024
Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on OsimertinibNathaniel D Robinson, Maureen E Canavan, Peter L Zhan, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2023
Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgeryBrooks V Udelsman, Maureen E Canavan, Peter L Zhan, et al.
JTO Clinical and Research Reports|September 30, 2021
Optimal Radiation Dose for Stage III Lung Cancer-Should "Definitive" Radiation Doses Be Used in the Preoperative Setting?Areo G Saffarzadeh, Maureen Canavan, Benjamin J Resio, et al.
JAMA Network Open|June 17, 2022
Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV CancerPeter L Zhan, Maureen E Canavan, Theresa Ermer, et al.
Pageof 21

Showing results (101-110 of 209) with videos related to

Sort By:
Pageof 21
The Annals of Thoracic Surgery|December 16, 2014
Hospital readmission after pulmonary lobectomy is not affected by surgical approachRoland Assi, Daniel J Wong, Daniel J Boffa, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 20, 2015
Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBaseJia Liu, Jacquelyn G Hancock, Amy C Moreno, et al.
The Annals of Thoracic Surgery|December 22, 2014
Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgeryJacquelyn G Hancock, Joshua E Rosen, Alberto Antonicelli, et al.
JAMA Oncology|November 11, 2021
Understanding the Implications of Medicaid Expansion for Cancer Care in the US: A ReviewTheresa Ermer, Samantha L Walters, Maureen E Canavan, et al.
JAMA Network Open|September 29, 2020
Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care ActMichelle C Salazar, Maureen E Canavan, Samantha L Walters, et al.
The Annals of Thoracic Surgery|November 7, 2020
A National Study of Surgically Managed Atypical Pulmonary Carcinoid TumorsSamantha L Walters, Maureen E Canavan, Michelle C Salazar, et al.
Clinical Lung Cancer|October 27, 2024
Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on OsimertinibNathaniel D Robinson, Maureen E Canavan, Peter L Zhan, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2023
Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgeryBrooks V Udelsman, Maureen E Canavan, Peter L Zhan, et al.
JTO Clinical and Research Reports|September 30, 2021
Optimal Radiation Dose for Stage III Lung Cancer-Should "Definitive" Radiation Doses Be Used in the Preoperative Setting?Areo G Saffarzadeh, Maureen Canavan, Benjamin J Resio, et al.
JAMA Network Open|June 17, 2022
Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV CancerPeter L Zhan, Maureen E Canavan, Theresa Ermer, et al.
Pageof 21